discovered a significant increase in the expression of SERPINB2 in MAFLD compared to simple steatosis, based on gene expression experiments in liver tissues from patients with non-alcoholic steatohepatitis. This evidence concerns the gene SERPINB2 and metabolic dysfunction-associated steatohepatitis.